Subsequent Event (Details) - Roots Pharmaceutical - Subsequent Event - Collaborative Arrangement, Transaction with Party to Collaborative Arrangement $ in Millions	Oct. 13, 2026 USD ($)
Subsequent Events
Collaborative arrangement, upfront license fees and near-term development milestones	$ 4.0
Collaborative arrangement contingent payment consideration to be received amount	$ 255.0
Collaborative arrangement contingent payment consideration to be percentage	22.00%

Collaborative Arrangement, Maximum Aggregate Milestone Payments

No definition available.

Name:	ocgn_CollaborativeArrangementMaximumAggregateMilestonePayments
Namespace Prefix:	ocgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Royalties To Be Received, Percentage Of Net Sales

+ References

No definition available.

+ Details

Name:	ocgn_CollaborativeArrangementRoyaltiesToBeReceivedPercentageOfNetSales
Namespace Prefix:	ocgn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Upfront License Fees And Near-Term Development Milestones

+ References

No definition available.

+ Details

Name:	ocgn_CollaborativeArrangementUpfrontLicenseFeesAndNearTermDevelopmentMilestones
Namespace Prefix:	ocgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=ocgn_RootsPharmaceuticalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: